FDA Adverse Event Injury Summary report: N

PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER

MDR report key: 4103582 · Received September 19, 2014

Report

Report Number
3005168196-2014-00657
Event Type
Injury
Date Received
September 19, 2014
Date of Event
August 20, 2014
Report Date
August 20, 2014
Manufacturer
PENUMBRA, INC.
Product Code
NRY
PMA / PMN Number
K090752
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Additional Manufacturer Narrative · 1

CONCLUSION CODE : HEMORRHAGE IS A KNOWN AND ANTICIPATED COMPLICATION WITH THESE TYPES OF PROCEDURES AND IS NOTED IN THE DEVICE LABELING. THEREFORE, IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION. DEVICE IS NOT AVAILABLE FOR RETURN.

Description of Event or Problem · 1

THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE IN THE RIGHT MIDDLE CEREBRAL ARTERY USING A PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER. AFTER SUCCESSFUL ASPIRATION USING THE 5MAX ACE REPERFUSION CATHETER, THE PATIENT DEVELOPED AN INTRACRANIAL HEMORRHAGE. THE RELATIONSHIP BETWEEN THE EVENT AND THE PENUMBRA SYSTEM IS POSSIBLE WITH THE SEVERITY BEING SEVERE. THE PATIENT'S CONDITION WAS REPORTED AS PARALYZED ON THE LEFT HAND SIDE WITH ADDITIONAL TREATMENT DUE TO BRAIN SWELLING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
582509 PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER NRY NRY PENUMBRA, INC. F43583

Patients

Seq Age Sex Outcome Treatment
1 63 YR Other